Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Marijuana Withdrawal and Relapse
NCT00373295Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- May 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of baclofen in cannabis use disorder (CUD) (6 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Change in Money Spent Between Baseline and Relapse Phase. Started May 2006; status: completed.
02
Drugs
baclofen
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00373295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373295.